The NIPRO Study: An Observational, Retrospective, Multicenter Study on the Safety of the Radiotherapy and Immunotherapy Combination for Advanced-Stage NSCLC-Reference-Cited by-同舟云学术

The NIPRO Study: An Observational, Retrospective, Multicenter Study on the Safety of the Radiotherapy and Immunotherapy Combination for Advanced-Stage NSCLC

Published:2021-09 Issue:5 Volume:22 Page:e767-e773
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Perna Marco^ORCID,Scotti Vieri,Ciammella Patrizia,Borghetti Paolo,D'angelo Elisa,Levra Niccolò Giaj,Fozza Alessandra,Mariotti Matteo,Salvestrini Viola^ORCID,Bertolini Federica,Vagge Stefano,Taraborrelli Maria,Falcinelli Lorenzo,Taddeo Alessandra,Rossi Roberto,Costantino Gianluca,Frassinelli Luca,Filippi Andrea Riccardo,Greco Carlo,Franceschini Davide,Genovesi Domenico,Lohr Frank^ORCID,Magrini Stefano Maria^ORCID,Alongi Filippo,Livi Lorenzo,Bruni Alessio

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference34 articles.

1. Real-world use and survival outcomes of immune checkpoint inhibitors in older adults with non-small cell lung cancer;Youn;Cancer,2020

2. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways;Fife;Immunol Rev,2008

3. Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study;Gomez;J Clin Oncol,2019

4. Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial;Palma;J Clin Oncol,2020

5. Oligometastasis and local ablation in the era of systemic targeted and immunotherapy;Mazzola;Radiat Oncol,2020

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetically light-enhanced immunotherapy mediated by a fluorinated reduction-sensitive delivery system;Biomaterials;2024-03

2. Radiotherapy to reinvigorate immunotherapy activity after acquired resistance in metastatic non-small-cell lung cancer: A pooled analysis of two institutions prospective phase II single arm trials;Radiotherapy and Oncology;2024-01

3. The Efficacy and Safety of Immunotherapy Followed by Thoracic Radiation in Advanced Non-small Cell Lung Cancer: A Retrospective Analysis;2023-12-02

4. Immunoradiotherapy for NSCLC: mechanisms, clinical outcomes, and future directions;Clinical and Translational Oncology;2023-11-03

5. Research progress of biomarkers in the prediction of anti-PD-1/PD-L1 immunotherapeutic efficiency in lung cancer;Frontiers in Immunology;2023-07-03